TrialCancer2019

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance).

Kristie A Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.